Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma [Phase 2, Phase 3]
Phase 2/3 trial evaluating microwave ablation combined with cellular immunotherapy for hepatocellular carcinoma completed.
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating sintilimab plus lenvatinib in locally advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy [NA]
Pilot study assessing theragnostically planned liver radiation to optimize radiation therapy for liver cancer, completed with posted results…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Study to Evaluate VORTX Rx (Theresa) [NA]
Completed clinical trial update for VORTX Rx (Theresa) evaluating hepatocellular carcinoma with liver metastases; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis [Phase 2]
Phase 2 trial update evaluating systemic chemotherapy plus lenvatinib and toripalimab for hepatocellular carcinoma with extrahepatic metasta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging [Phase 2]
Phase 2 trial investigating hypoxic changes in hepatocellular carcinoma after transarterial chemoembolization and stereotactic radiation usi…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma [Phase 3]
Phase 3 trial evaluating DEB-TACE in combination with lenvatinib, sorafenib, or a PD-1 inhibitor for unresectable hepatocellular carcinoma i…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 study evaluating HX008 in combination with bevacizumab or lenvatinib for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies [Phase 1, Phase 2]
Clinical trial update on autologous CAR-T/TCR-T cell therapy for solid malignancies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies [EARLY_Phase 1]
Early phase1 trial evaluating vandetanib-eluting radiopaque embolic beads for resectable liver malignancies has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial of LEE001 in combination with Chemoembolization in advanced hepatocellular carcinoma was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects [Phase 3]
A Phase III study comparing Icaritin to Huachansu Pian in advanced HBV-related hepatocellular carcinoma is in Phase 3 with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase II study updates for icartin in advanced hepatocellular carcinoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma. [Phase 2, Phase 3]
A clinical trial evaluating sintilimab with IBI305 versus sorafenib as first-line therapy for advanced hepatocellular carcinoma (PHASE 2/3).…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence [Phase 2]
Phase 2 trial evaluating pravastatin to delay recurrence of hepatocellular carcinoma in patients with liver cirrhosis was terminated; result…
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of cTACE or DEB-TACE plus FOLFOX-based hepatic arterial infusion chemotherapy with camre…
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial [Phase 3]
A randomized Phase 3 trial comparing high-dose versus lower-dose oxaliplatin-containing HAIC regimens combined with sorafenib or lenvatinib …
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions [NA]
A completed clinical trial evaluating a novel free-breathing MRI quantification technique for assessing liver lesions in hepatocellular carc…
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma [Phase 1]
Phase 1 trial evaluating lenvatinib plus pembrolizumab in hepatocellular carcinoma has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection [Phase 3]
Phase III trial in adjuvant treatment of hepatitis virus–related hepatocellular carcinoma after surgical resection was terminated; results p…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection [Phase 3]
Phase 3 trial evaluating sintilimab plus bevacizumab as adjuvant therapy for hepatocellular carcinoma at high risk of recurrence after curat…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial exploring regorafenib plus tislelizumab as first-line systemic therapy for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial of dalantercept combined with sorafenib in advanced hepatocellular carcinoma has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating emibetuzumab in combination with ramucirumab in various advanced cancers, with completed status and results poste…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression [Phase 1, Phase 2]
Phase 1/2 study of FGF401 in hepatocellular carcinoma and other solid tumors characterized by FGFR4 and KLB expression has completed. Result…